About
Katharina Sophia Volz is a medical researcher and entrepreneur best known as the founder and CEO of OccamzRazor, an AI-enabled biotech company focused on brain-aging disorders including Parkinson's disease. Public profiles describe her as the first recipient of Stanford's PhD in stem cell biology and regenerative medicine and as a founder building machine-learning tools for drug discovery. Her public role is primarily that of a scientist-founder, speaker, and startup operator rather than an investor or fund manager.
Areas of interest
biotechmachine learningAI drug discoveryParkinson's diseasebrain agingneurodegenerationregenerative medicinedigital science